Arbutus Biopharma Corp (ABUS) Insider Trading -- Recent Executive & Director Transactions

4 insiders reported 14 Form 4 transactions for Arbutus Biopharma Corp (ABUS) over the past 18 months (most recent 2026-09-23). Recent activity: Beardsley Robert A (Director) Buy 52,533 shares, Sawhney Roger (Director) Buy 52,533 shares, Androski Lindsay (President and CEO) Buy 116,408 shares, Nguyen Tuan (Chief Financial Officer) Buy 265,625 shares, Beardsley Robert A (Director) Buy 78,800 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-23Beardsley Robert ADirectorBuy52,533$168,106
2026-09-23Sawhney RogerDirectorBuy52,533$175,460
2026-09-23Androski LindsayPresident and CEOBuy116,408$372,506
2026-09-23Nguyen TuanChief Financial OfficerBuy265,625$927,031
2026-09-23Beardsley Robert ADirectorBuy78,800$334,112
2026-09-23Sawhney RogerDirectorBuy78,800$334,112
2026-09-23Androski LindsayPresident and CEOBuy10,456$45,902
2026-09-23Nguyen TuanChief Financial OfficerBuy27,475$120,615
2026-09-23Beardsley Robert ADirectorSell99,057$502,219
2026-09-23Sawhney RogerDirectorSell100,508$509,576
2026-09-23Androski LindsayPresident and CEOSell82,527$418,412
2026-09-23Nguyen TuanChief Financial OfficerSell206,637$1.0M
2026-02-02Androski LindsayPresident and CEOBuy28,000$0
2026-02-02Nguyen TuanChief Financial OfficerBuy73,500$0

来源:SEC Form 4 申报文件 · 截至 2026-09-23